Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IB Trial of Metformin, Digoxin, Simvastatin in Subjects With Advanced Pancreatic Cancer and Other Advanced Solid Tumors

NCT03889795 is registered in ClinicalTrials.gov with Danae Hamouda, MD as lead sponsor.

NCT NCT03889795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03889795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IB Trial of Metformin, Digoxin, Simvastatin in Subjects With Advanced Pancreatic Cancer and Other Advanced Solid Tumors
Lead sponsor
Danae Hamouda, MD
Phase
Phase 1
Overall status
Active, not recruiting
Start date
June 5, 2019
Completion date
December 30, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced pancreatic cancer, advanced solid tumor